Berkeley Lights Net Income 2019-2021 | BLI

Berkeley Lights net income from 2019 to 2021. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Berkeley Lights Annual Net Income
(Millions of US $)
2020 $-42
2019 $-18
2018 $-23
Berkeley Lights Quarterly Net Income
(Millions of US $)
2021-06-30 $-18
2021-03-31 $-15
2020-12-31 $-11
2020-09-30 $-9
2020-06-30 $-13
2020-03-31 $-9
2019-12-31
2019-09-30 $-4
2019-06-30 $-6
2018-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.711B $0.064B
Berkeley Lights Inc. is a Digital Cell Biology company. It focuses on development and commercialization of biotherapeutics and other cell-based products. Berkeley Lights Inc. is based in EMERYVILLE, Calif.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.683B 8.63
Bio-Rad Laboratories (BIO.B) United States $21.975B 46.83
QIAGEN (QGEN) Netherlands $11.773B 19.94
Biohaven Pharmaceutical Holding (BHVN) United States $8.738B 0.00
Emergent Biosolutions (EBS) United States $2.722B 6.57
Arcus Biosciences (RCUS) United States $2.455B 0.00
Myovant Sciences (MYOV) United Kingdom $1.915B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.755B 0.00
Zymeworks (ZYME) Canada $1.208B 0.00
Ambrx Biopharma (AMAM) United States $0.470B 0.00
SQZ Biotechnologies (SQZ) United States $0.342B 0.00
Enzo Biochem (ENZ) United States $0.183B 18.00